title: Effect of 32P treatment for polycythaemia vera on blood lymphocyte subpopulations and their functions.
abstract: The influence of 32P treatment on the blood lymphocyte population was examined in 16 patients with polycythaemia vera who had not previously been treated with cytotoxic drugs or irradiation. Before treatment the lymphocyte counts were within the normal range but the expression of certain membrane structures, as detected by monoclonal antibodies directed against total T cells (CD 3 and 5), helper/inducer (CD 4) and suppressor/cytotoxic T cells (CD 8), were slightly reduced. In addition, mitogenic responses of the lymphocytes to PHA and PWM-induced Ig secretion were severely impaired. Following a single oral dose of 32P (150-305 MBq), which was shown to normalize the production of erythrocytes and/or platelets, the blood lymphocyte counts were reduced by approximately 40% 12 wk after treatment. Subset analysis showed that the proportion of B cells, as identified by monoclonal antibodies (CD 20), was reduced to the highest relative extent. On the other hand, lymphocytes expressing the above T cell markers were somewhat increased. 32P treatment sharply increased PHA reactivity but it further reduced PWM-induced Ig secretion. The latter observation was in line with the finding that serum concentrations of Ig were reduced following treatment.
authors: Stockholm County Council, Central Microbiological Laboratory, Sweden.
authors: B
authors: B
authors: Petrini
authors: H
authors: H
authors: Blomgren
authors: J
authors: J
authors: Wasserman
authors: E
authors: E
authors: Svedmyr
authors: L V
authors: LV
authors: Stedingk
authors: P O
authors: PO
authors: Schnell
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001773:Blood Cells / Q000145:classification*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count / Q000187:drug effects; D008214:Lymphocytes / Q000145:classification* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000097:blood / Q000188:drug therapy* / Q000473:pathology
chemical_list: D007136:Immunoglobulins; D010761:Phosphorus Radioisotopes